Charles Urquhart, MD
Plastic and Reconstructive Surgery · Anniston, ALNPI 1285606897
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $913 of the $1,071 with a category attached, or 85.3%. 12 manufacturers reported payments, led by AbbVie at 53.6% of the total. That places this record below the midpoint for plastic and reconstructive surgery clinicians in AL, where the typical reported total is $1,100.
Across 53 payments — averaging $20.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$574
- Bard Peripheral Vascular, Inc.$117
- Davol Inc.$101
- Mentor Worldwide LLC$55
- Johnson & Johnson$48
- Vertex$44
- plus $132 from 6 others
What the payments were for
- Speaking & faculty fees$15815%
- Food & beverage$91385%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 29 | $574 |
| Bard Peripheral Vascular, Inc. | 7 | $117 |
| Davol Inc. | 2 | $101 |
| Mentor Worldwide LLC | 2 | $55 |
| Johnson & Johnson(2 entities) | 3 | $48 |
| Vertex | 2 | $44 |
| TELA Bio, Inc. | 2 | $32 |
| Medtronic(2 entities) | 2 | $27 |
| Silk Road Medical, Inc. | 1 | $24 |
| Angiodynamics, Inc. | 1 | $19 |
| Mallinckrodt Enterprises LLC | 1 | $16 |
| Cumberland Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$1,071 in reported general payments places this provider in the 45th percentile of 35 plastic and reconstructive surgery providers in Alabama.
See all plastic and reconstructive surgery providers in Alabama →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Famotidine | 12 | $269 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 23 | $99 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 17 | $65 |
| Cephalexin | 16 | $51 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Anniston
- Robert BollingTuscaloosa$71K
- Brad DenneyBirmingham$21K
- Tony WeaverHuntsville$13K
- Michael BeckensteinBirmingham$10K
- Jeffery WaldingDothan$10K
- Robert OliverBirmingham$7K
- Paul SauerBirmingham$6K
- Michael BentleyMontgomery$5K
- John RobertsonMontgomery$5K
- Jonathan AntonettiBirmingham$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.